Johnson & Johnson (JNJ)

166.00
-11.80(-6.64%)
  • Volume:
    21
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    166.00 - 166.00

JNJ Overview

Prev. Close
-
Day's Range
166-166
Revenue
47.45B
Open
166
52 wk Range
158.8-186
EPS
6.98
Volume
21
Market Cap
438.34B
Dividend (Yield)
4.52
(2.72%)
Average Volume (3m)
14
P/E Ratio
23.69
Beta
0.589
1-Year Change
-2.84%
Shares Outstanding
2,629,179,895
Next Earnings Date
17 Oct 2022
What is your sentiment on J&J?
or
Market is currently closed. Voting is open during market hours.

Johnson & Johnson News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Johnson & Johnson Analysis

Johnson & Johnson Company Profile

Johnson & Johnson Company Profile

Employees
141700
  • Type:Equity
  • Market:Peru
  • ISIN:US4781601046
  • S/N:JNJ

Johnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Read More

Analyst Price Target

Average189.82 (+13.86% Upside)
High215
Low173
Price166.72
No. of Analysts17
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesNeutralNeutralNeutral
Technical IndicatorsStrong SellStrong SellNeutral
SummarySellSellNeutral
  • Interest rates?
    0
    • FDA approved finally. Few minutes ago!!!!
      0
      • What?
        0
    • Invested in J&J a couples years back and have closely followed the pharmaceutical industry. Found a company by the name of SpectrumX which has an IPO set for November. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trails for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
      0
      • To entry in Spectrum or not? What do you think?
        0
      • Checking it out looks like a good punt
        0
    • Good job JNJ. move forward bullish
      0
      • Stock split???
        0
        • Where we go next?
          0
          • AMC! But ultimately it’s your decision.
            0
        • Good buy. 0at this price
          0
          • JNJ is going to Make a strong come back tonight!
            1
            • Immediate inquiry must be done
              4